Paediatrica Indonesiana

Similar documents
Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: Initial clinical applications in children

TRANSCATHETER CLOSURE OF PERSISTENT DUCTUS ARTERIOSUS USING THE AMPLATZER DUCT OCCLUDER IN INFANTS

IMAGES. in PAEDIATRIC CARDIOLOGY. Abstract

Original Policy Date

PDA: Closure Using Coils and Devices: Indications, Technique & Outcome

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Reopening After Successful Coil Occlusion for Patent Ductus Arteriosus

Hybrid Muscular VSD Closure in Small Weight Children

PDA Device Closure with and without Arterial Access

Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute

COMPLEMENTARY TECHNIQUES OF PERCUTANEOUS CLOSURE OF DUCTUS ARTERIOSUS USING DETACHABLE COOK COILS AND AMPLATZER DEVICES

Patient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the

Evaluation of Gianturco Coils for Closure of Large (> 3.5 mm) Patent Ductus Arteriosus

Paediatrica Indonesiana. Echocardiographic patterns in asphyxiated neonates. Maswin Masyhur, Idham Amir, Sukman Tulus Putra, Alan Roland Tumbelaka

AMPLATZER Septal Occluder Structural Heart Therapy. Over 15 years of. Demonstrated. Clinical Experience. We ll show you our data. Ask to see theirs.

Perventricular Closure of Muscular VSD

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier

Type Size AP/PS RP/RS Qp/Qs. Ia Resistive <0.3 < Ib Resistive <0.3 < IIa Resistive <0.5 >2

Introduction. Study Design. Background. Operative Procedure-I

Transcatheter Closure of Atrial Septal Defects in a Center With Limited Resources: Outcomes and Short Term Follow-Up

Transcatheter device occlusion of patent ductus arteriosus

Initial Human Experience. Objectives: To evaluate the feasibility, safety, and efficacy of the Occlutech VR

CONGENITAL HEART DEFECTS IN ADULTS

Anatomy & Physiology

Perimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin. Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong

COST AND EFFICACY OF SURGICAL LIGATION VERSUS TRANSCATHETER COIL OCCLUSION OF PATENT DUCTUS ARTERIOSUS

Nit-Occlud. Coil System for PDA Closure PATIENT EDUCATIONAL BROCHURE

2) VSD & PDA - Dr. Aso

Pathophysiology: Left To Right Shunts

Short-Term Outcome Of Different Treatment Modalities Of Patent Ductus Arteriosus In Preterm Infants. Five Years Experiences In Qatar

Congenital heart disease. By Dr Saima Ali Professor of pediatrics

Congenital Cardiac Anesthesia as a Specialty: Where We ve Been & Where We re Going

Predictors of unfavorable outcome after atrial septal defect closure in adults

Cardiolog procedure availabl a Davie Veterinar Specialist

Journal of the American College of Cardiology Vol. 33, No. 5, by the American College of Cardiology ISSN /99/$20.

Reliability of Echocardiography Measurement of Patent Ductus Arteriosus Minimum Diameter: A Meta-analysis

Transcatheter Closure of Patent Ductus Arteriosus Using ADO Device: Retrospective Study of 149 Patients

Pattern of Congenital Heart Disease A Hospital-Based Study *Sadiq Mohammed Al-Hamash MBChB, FICMS

Long-Term Results of Transcatheter Closure of Patent Ductus Arteriosus in Infants Using Amplatzer Duct Occluder

Nit-Occlud. Coil System for PDA Closure IMPLANTATION POCKET GUIDE. Rx only CV / B. Braun Interventional Systems Inc.

CARDIAC INTERVENTIONS IN PEDIATRIC CARDIOLOGY: THE FUTURE

Transcatheter closure of right coronary artery fistula to the right ventricle

Γεώργιος Δ. Κατσιμαγκλής. Αν. Διευθυντής Καρδιολογικής ΚλινικήςΝΝΑ Διευθυντής Αιμοδυναμικού Εργαστηρίου ΝΝΑ

Pathophysiology: Left To Right Shunts

RESPECT Safety Findings

1. Definition/Overview

Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder.

Jian Fang 1, Shaobo Xie 2, Lunchao Ma 2, Chao Yang 2. Original Article

Therapeutic Cardiac Catheterizations for Children with Congenital Heart Disease

Patent Ductus Arteriosus (PDA)

"Lecture Index. 1) Heart Progenitors. 2) Cardiac Tube Formation. 3) Valvulogenesis and Chamber Formation. 4) Epicardium Development.

AMPLATZER Septal Occluder

SCAI Expert Consensus Statement for Advanced Training Programs in Pediatric and Congenital Interventional Cardiac Catheterization

Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institutional database. Carlos M.

Transcatheter Atrial Septa1 Defect Closure: Preliminary Experience with the Rashkind Occluder Device

Originally Posted: November 15, 2014 BRUIT IN THE GROIN

In the current era, transcatheter occlusion of the patent

UNMH Pediatric Cardiology Clinical Privileges. Name: Effective Dates: From To

Paediatrics Revision Session Cardiology. Emma Walker 7 th May 2016

Perventricular Closure of Muscular VSD s

(2013 ) ACHD ACHD

IMAGES. in PAEDIATRIC CARDIOLOGY

INTEGRATING ECHOCARDIOGRAPHY WITH CATHETER INTERVENTIONS FOR CONGENITAL HEART DISEASE. Krishna Kumar SevenHills Hospital, Mumbai, India

Update on mangement of patent ductus arteriosus in preterm infants. Dr. Trinh Thi Thu Ha

Adult Congenital Heart Disease T S U N ` A M I!

Down Syndrome Medical Interest Group Friday, 12 June Cardiac Surgery in patients with Down Syndrome

Recommendations for Hospital Quality Measures in 2011:

Patent Ductus Arteriosus: Philosophy or Pathology?

THE SPECTRUM OF PAEDIATRIC CARDIAC DISEASE IN VANUATU. Dr Annette Garae (PGDCH)

Atrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs

Closing your Patent Ductus Arteriosus (PDA)

Deok Young Choi, Gil Hospital, Gachon University NEONATES WITH EBSTEIN S ANOMALY: PROBLEMS AND SOLUTION

Screening for Critical Congenital Heart Disease

MEDICAL SCIENCES Vol.I -Adult Congenital Heart Disease: A Challenging Population - Khalid Aly Sorour

Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict

6). However, for cases in which an ASO cannot

Collaborative programme in paediatric cardiac surgery in Ethiopia: Nursing role

Transcatheter closure of interatrial

ΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ

Patient Ductus Arteriosus (PDA)

Pediatric PAH after successful neonatal arterial switch operation for transposition of the great arteries

Case submission for CSI Asia-Pacific Case 2

Patient Information. Atrial Septal Defect (ASD) Repair

September 26, 2012 Philip Stockwell, MD Lifespan CVI Assistant Professor of Medicine (Clinical)

Repair or Replacement

INDUSTRY OVERVIEW ABOUT BIOMEDGPS, LLC

5 th Asia Pacific Congenital and Structural Heart (APCASH) Intervention Symposium 2014

Uptofate Study Summary

PFO Management update

5.8 Congenital Heart Disease

Slide 1. Slide 2. Slide 3 CONGENITAL HEART DISEASE. Papworth Hospital NHS Trust INTRODUCTION. Jakub Kadlec/Catherine Sudarshan INTRODUCTION

Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications

NIH Public Access Author Manuscript Congenit Heart Dis. Author manuscript; available in PMC 2014 November 21.

Complications of cardiac catheterization in pediatric patients: a single center experience

DIAGNOSIS, MANAGEMENT AND OUTCOME OF HEART DISEASE IN SUDANESE PATIENTS

Transcatheter closure of patent ductus arteriosus with the Rashkind occluder

Balloon Valvuloplasty Through the Right Ventricle: Another Treatment of Pulmonary Atresia With Intact Ventricular Septum

Glenmark Cardiac Centre Mumbai, India

NEONATAL HYBRID PROCEDURES STRATEGIES TO REDUCE MORBIDITY AND MORTALITY

Transcription:

Paediatrica Indonesiana VOLUME 53 July NUMBER 4 Original Article Transcatheter vs. surgical closure of patent ductus arteriosus: outcomes and cost analysis Mulyadi M Djer, Mochammading, Mardjanis Said Abstract Background congenital heart disease (CHD) caused by the patency of the arterial duct after birth. For the last three decades, management of PDA with transcatheter closure has been gaining popularity, including in developing countries. However its effectiveness in terms of clinical outcomes and cost may vary among center and Objectives To compare the cost and clinical effectiveness of PDA closure using transcatheter approach compared to surgical ligation. Methods We performed a retrospective review on patients underwent either transcatheter or surgical closure of PDA between and categorical variables, respectively Results closure using an Amplatzer device occluder (ADO) device and children with unsuccessful transcatheter closure eventually had their PDA closed by surgery, whereas one child with residual PDA after surgical closure had his PDA closed by coil. No residual PDA Duration of hospitalization was significantly less for patients having Amplatzer Conclusion transcatheter closure although the cost is higher than surgical ligation. [Paediatr Indones. 2013;53:23944.]. Keywords: persistent ductus arteriosus, Amplatzer duct occluder, surgical ligation, cost analysis P congenital heart disease (CHD) caused by the patency of arterial duct after birth. the presence of PDA, a closure is currently almost always indicated, especially for the moderate to large PDA, to prevent or treat symptoms associated with this lesion. percutaneous transcatheter procedure has been advocated in the last three decades. One of the most popular device used for the transcatheter closure is the Amplatzer duct occluder or ADO (AGA Medical Co, Golden Valley, MN, US) which had been recommended by Food and Drugs Association (FDA) US Previous studies reported that the rate of This procedure is mostly preferable over surgery because it is less invasive and results in minimal complication, fewer hospitalization days, and without surgery scar. However, there are also concerns about higher cost put by the PDA transcatheter closure procedure, which may differ among centers. Since clinical Reprint requests to: Mulyadi M. Djer, Pediatric Cardiology Division, m. Paediatr Indones, Vol. 53, No. 4, July 2013 239

outcomes and cost are very important in a health outcomes and cost of PDA closure by transcatheter methods using ADO device compared to surgical ligation. Methods We performed a retrospective review on all patients those with multiple congenital anomalies. The primary outcomes of this study were direct cost of PDA transcatheter closure compared to surgical ligation. The PDA transcatheter closure procedures were started to be performed in our medical records: age, immediate results (complete or incomplete closure) at discharge, rate of closure the procedure and hospitalization, length of stay, and the presence of residual PDA. Complications were classified as major (death, cardiac tamponade, cardiac arrest) and minor (transient badycardia or tachycardia). The procedure cost was analyzed using the cost minimization analysis method. Direct medical cost was calculated for the duration of hospitalization, hardware cost (catheterization laboratory operational cost, ADO device, anaesthesia drugs, pharmaceutical cost), laboratory and imaging investigations.. All included in the cost analysis. We aimed to compare the outcomes and cost of transcatheter PDA closure using transcatheter versus respectively. All statistical analyses were done using an SPSS for Windows version 17 computer software program. Results of the patients in the transcatheter closure group was significantly older from that of the surgery group (Table 1 median duct size in the transcatheter closure group no statistical significant difference was found between PDA transcatheter closure and surgery, which was Table 2 describes the clinical outcomes of PDA transcatheter closure using an ADO device compared to surgery. The rate of complete closure at discharge was slightly better in the transcatheter Table 1. Characteristics of the study subjects. Characteristics Gender Males, n (%) Median age (range), years* Median procedure time (range), minutes Median weight (range), kg* Median diameter of PDA (range), mm* * P value <0.001 with Mann Whitney test. Procedures Transcatheter closure (n = 89) 21 (24) 4 (0.5 13) 70 (45 165) 13 (4.5 33) 4 (1.3 13) Surgical ligation (n = 67) 21 (31) 1.8 (0.5 12) 75 (30 240) 8 (2.1 33) 6 (3 11) 240 Paediatr Indones, Vol. 53, No. 4, July 2013

device embolized so they were referred for surgery. small residual shunt, but they were decided to be discharged for further observation. with small residual shunt from the transcatheter closure and surgery group, respectively, eventually achieved complete closure. One patient who still had persistent shunt after surgical PDA ligation finally had his residual PDA closed transcatheterly using a coil. No statistical significant difference was found in terms of complication rate between the two groups, however the duration of hospitalization was significantly lower in the transcatheter closure group compared to Two patients, one from each group, had fever after the PDA closure and were treated with antibiotics. Table 3 presents the details of total direct cost of transcatheter closure compared to surgical procedures. Overall, the transcatheter closure costed higher than that of surgery. However this higher cost was mostly attributed to the cost for supporting operation facilities, such as the catheterization laboratory along other hand, the costs for hospitalization, pharmacy, in the transcatheter closure group compared to pharmaceutical costs for transcatheter closure was Table 2. Clinical outcomes of transcatheter closure vs. surgical ligation Clinical outcomes Procedures P value Result at discharge (>24 hr), n (%) Complete closure Small residual shunt Large residual shunt Result on followup (± 7 days), n (%) Complete closure Small residual shunt Large residual shunt Complications, n (%) No complication Minor complication Mayor complication Transcatheter closure (n = 89) 85 (96) 2 (2) 2 (2) 87 (98) 86 (97) 1 (1) Surgical ligation (n = 67) 63 (94) 4 (6) 66 (98) 1 (2)* 64 (96) 2 (3) 1.000 1.000 1.000 2.7 (SD 1.5) 6.6 (SD 1.5) <0.0001 Death, n (%) 0 (0) 2 (3) 1.000 P value of chisquare test; occlusion; ** result expressed as mean standard deviation, P value for T test for independent sample; caused complication. Table 3. Cost comparison of transcatheter closure vs. surgical ligation Type of cost (Rp, x 1000) Transcatheter closure (n = 89) Procedures Surgical ligation (n = 67) P value SOF cost 29,021 11,083 N/A 166 (83 1,245) 1,825(1,576 22,643) P< 0.0001 Median pharmaceutical cost (range) 332 (7.3 2,490) 3,650 (3,152 45,286) P< 0.0001 Mean laboratory cost (SD) 847.7 (SD 57.2) 1,033 (SD 89.25) P<0.0001** Mean total cost (SD) 29,930 (SD 57.2) 12,205 (SD 89.3) SOF, supporting operation facilities; *N/A, not applicable; Mann Whitney test;** independent T test Paediatr Indones, Vol. 53, No. 4, July 2013 241

Discussion transcatheter methods was slightly more effective in achieving complete closure compared to surgery and resulted in higher total cost than surgery. A decision for planning PDA transcatheter rations, including patient sage, size of the duct, and who underwent transcatheter closure were older and had smaller PDA diameter compared to those who had surgery. However, some literatures state that transcatheter procedure is feasible for infants On the other hand, in surgical ligation, age and weight is not an absolute consideration, so that it remains as the procedure of choice for some cases, such as premature infants who do not respond to indomethacin, patients with complications, or those who failed transcatheter closure approach. age and weight at transcatheter closure procedure. Differ from our study, they reported almost comparable age between the transcatheter and surgery group, ter PDA closure procedure is not only determined by the skill of the operator, but also by the age of the such as pneumonia, or any severe symptom of heart failure may affect the choice of management. Surgical ligation is usually preferred over transcatheter closure when the above conditions limit the feasibility of transcatheter approach. Whether or not a patient achieves complete closure reflects the effectiveness of PDA management. ligation showed similar results with the rate of results were almost the same with previous study comparing surgical ligation with and transcatheter their patients had smaller PDA diameter compared to ours. Another study reported that percutaneous transcatheter procedure is less effective compared to respectively. However the number of patients in that study was limited. Patent ductus arterious complete closure may be achieved rapidly after surgical ligation and the outcomes On the other hand, after a transcatheter closure using an closure of the PDA.The thrombogenic polyester material in the inner part of an ADO needs certain period to induce complete thrombosis in the PDA surrounding area. Accurate selection of the ADO size and delivery system (micro screw cable and delivery system) determine the success of the transcatheter closure. of cases handled increase. A multicentre study on the effectiveness of immediate complete closure after transcatheter PDA Residual shunt, which commonly occurs in surgical ligation, used by surgeons in our center was the double ligation the surgeon could not ligate a PDA too tight because of the potential rupture of the duct tissue due to its fragility. Many studies have evaluated various in January Previously, Mavroudis et al recommended ligation acomplete closure. This study revealed that both the transcatheter procedure and surgery were safe, in which they resulted in minimal complication and no mortality. 242 Paediatr Indones, Vol. 53, No. 4, July 2013

The difference in length of stay between the two groups was more related to the choice of procedure. The ligation procedure is considered as a major surgery that demands close monitoring after surgery transcatheter closure procedure is far less invasive. The monitoring and care after the procedure can be done in a regular ward and patients can be discharged Cost minimization analysis is a method that only evaluates the total cost of interventions with ligation procedure was found to be cheaper than the transcatheter closure using an ADO for a relatively of the SOF cost was allocated for the ADO unit. On the other hand, the ligation procedure does not need for the surgical procedure. Previous studies found similar results, either that used Gianturco coils or Rashkind occluder. Moreover, the total cost of Gianturco coil procedure was far higher than ligation contrast to the above studies, a study by Prieto et al cheaper cost of coils and the use of local anesthesia in all patients. results of studies comparing the transcatheter and costs and clinical outcomes between surgical ligation and transcatheter procedure found no cost difference with comparable effectiveness. Another study in Australia, for atrial septal defect (ASD) closure using the Amplatzer septal occlude (ASO) also found no difference in median cost between the transcatheter methods and surgery although the ASO device was caused by higher cost of treatment, laboratory, and medication put by surgery. The results of the cost analysis in this study was largely influenced by the currency value of USD against Rupiah as we imported the ADO device. The calculation of the cost did not also include the use of anesthetics drugs, intravenous fluids, and disposable procedure and hospitalization cost, the total cost of surgical ligation in our study might be greater than the ADO procedure. The results of the cost analysis might also be different if indirect cost was included in the study, such as the cost of patients care giver and the loss of productivity of the family. Because it is a retrospective study, we can not calculate the indirect cost. closure using ADO is similar to surgical ligation, but in terms of cost, it is not as efficient as surgical. The advantage of ADO procedure are related to shorter hospitalization days and less invasiveness and therefore it may be recommended as the primary choice for PDA treatment. A prospective study needs to be done in the future to assess the analysis of cost effectiveness incorporating the indirect cost. References Freedom RM, Benson LN, Smallhorn JF, editors. Neonatal 4. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 5. Lloyd TR, Beekman RH. Transcatheter closure of atrial nd edition. J, De Groote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus erteriosus. N Engl Paediatr Indones, Vol. 53, No. 4, July 2013 243

G. Transcatheter closure of the patent ductus arteriosus with Midterm results of transcatheter closure of moderate to Goussous Y, et al. Catheter closure of moderate to large sized patent ductus arteriosus using the new Amplatzer Sastroasmoro S. Transcatheter closure of patent ductus patent ductus arteriosus division at Children s Memorial Hospital of Chicago. Standards for comparison. Ann Surg. Latson LA. Comparison of cost and clinical outcome between transcatheter coil occlusion and surgical closure of isolated charges for closure of patent ductus arteriosus by surgery and Transcatheter closure of persistent ductus arteriosus in infants assessment of nonsurgical closure of patent ductus arteriosus: an evaluation of the clinical effectivenessand costs of a new of transcatheter patent ductus arteriosus closure using Multicenter USA Amplatzer patent ductus arteriosus K, et al. Patency or recanalization of the arterial duct after of surgical versus transcatheter closure of patent ductus arteriosus: should you let a smile be your umbrella. Med comparison of costs and short term health outcomes of surgical versus device closure of atrial defect in children. 244 Paediatr Indones, Vol. 53, No. 4, July 2013